Causes and Prevention of Calcium-containing Renal Calculi

Overview

Journal West J Med

Specialty General Medicine

Date 1991 Sep 1

PMID 1949770

Citations 1

Authors

R A Sutton

Affiliations

Soon will be listed here.

Abstract

Kidney stones are common, and recurrences are the rule. At least 90% of patients with kidney stones probably have some identifiable metabolic risk factor. Effective prophylaxis is often available, but with the relatively low rate of recurrence, compliance with the treatment may be a problem. Studies are required to determine the cost-effectiveness of metabolic investigation and prophylactic therapy versus the possible need for repeated treatment by means of extracorporeal lithotripsy, especially in patients having a first calcium oxalate stone.

Citing Articles

How we get stoned.

SMITH Jr L West J Med. 1991; 155(3):306-7.

PMID: 1949794 PMC: 1003003.

References

Bushinsky D, Favus M . Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport. J Clin Invest. 1988; 82(5):1585-91. PMC: 442727. DOI: 10.1172/JCI113770. View

Bianchi G, Vezzoli G, Cusi D, Cova T, Elli A, Soldati L . Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria. N Engl J Med. 1988; 319(14):897-901. DOI: 10.1056/NEJM198810063191402. View

Lindsjo M, Fellstrom B, Ljunghall S, Wikstrom B, Danielson B . Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet. 1989; 2(8665):701-4. DOI: 10.1016/s0140-6736(89)90769-1. View

LaCroix A, Wienpahl J, White L, Wallace R, Scherr P, George L . Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med. 1990; 322(5):286-90. DOI: 10.1056/NEJM199002013220502. View

Pacifici R, ROTHSTEIN M, Rifas L, Lau K, Baylink D, Avioli L . Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab. 1990; 71(1):138-45. DOI: 10.1210/jcem-71-1-138. View

Silverberg S, Shane E, JACOBS T, Siris E, Gartenberg F, Seldin D . Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med. 1990; 89(3):327-34. DOI: 10.1016/0002-9343(90)90346-f. View

Coe F, Parks J . Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990; 38(4):625-31. DOI: 10.1038/ki.1990.252. View

Hess B, Nakagawa Y, Coe F . Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol. 1989; 257(1 Pt 2):F99-106. DOI: 10.1152/ajprenal.1989.257.1.F99. View

Pak C, Holt K . Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism. 1976; 25(6):665-73. DOI: 10.1016/0026-0495(76)90064-0. View

10.

YENDT E, Cohanim M . Prevention of calcium stones with thiazides. Kidney Int. 1978; 13(5):397-409. DOI: 10.1038/ki.1978.58. View

11.

Nicar M, Skurla C, Sakhaee K, Pak C . Low urinary citrate excretion in nephrolithiasis. Urology. 1983; 21(1):8-14. DOI: 10.1016/0090-4295(83)90113-9. View

12.

Barkin J, Wilson D, MANUEL M, Bayley A, Murray T, Harrison J . Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab. 1985; 11(1):19-24. View

13.

Karniski L, Aronson P . Chloride/formate exchange with formic acid recycling: a mechanism of active chloride transport across epithelial membranes. Proc Natl Acad Sci U S A. 1985; 82(18):6362-5. PMC: 391054. DOI: 10.1073/pnas.82.18.6362. View

14.

Nakagawa Y, Abram V, Parks J, Lau H, Kawooya J, Coe F . Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985; 76(4):1455-62. PMC: 424101. DOI: 10.1172/JCI112124. View

15.

Baggio B, Gambaro G, Marchini F, Cicerello E, Tenconi R, Clementi M . An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics. N Engl J Med. 1986; 314(10):599-604. DOI: 10.1056/NEJM198603063141002. View

16.

Danpure C, Jennings P . Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett. 1986; 201(1):20-4. DOI: 10.1016/0014-5793(86)80563-4. View

17.

Sutton R, Walker V . Bone resorption and hypercalciuria in calcium stoneformers. Metabolism. 1986; 35(6):485-8. DOI: 10.1016/0026-0495(86)90002-8. View

18.

Patron P, Gardin J, Paillard M . Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int. 1987; 31(5):1174-80. DOI: 10.1038/ki.1987.125. View

19.

Ljunghall S, Lithell H, Skarfors E . Prevalence of renal stones in 60-year-old men. A 10-year follow-up study of a health survey. Br J Urol. 1987; 60(1):10-3. DOI: 10.1111/j.1464-410x.1987.tb09123.x. View

20.

Karniski L, Aronson P . Anion exchange pathways for Cl- transport in rabbit renal microvillus membranes. Am J Physiol. 1987; 253(3 Pt 2):F513-21. DOI: 10.1152/ajprenal.1987.253.3.F513. View